Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.032 AUD | +0.73% | -3.29% | +232.26% |
Apr. 01 | ADRs End Higher; Connect Biopharma Climbs 26% | DJ |
Mar. 28 | ADRs End Lower; NuCana Slides 15% | DJ |
Sales 2024 * | 11.52M 7.69M | Sales 2025 * | 24.85M 16.58M | Capitalization | 1.17B 781M |
---|---|---|---|---|---|
Net income 2024 * | -103M -68.73M | Net income 2025 * | -121M -80.74M | EV / Sales 2024 * | 106 x |
Net Debt 2024 * | 55.05M 36.74M | Net Debt 2025 * | 93.28M 62.25M | EV / Sales 2025 * | 50.8 x |
P/E ratio 2024 * |
-9.66
x | P/E ratio 2025 * |
-9.52
x | Employees | 83 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.15% |
Latest transcript on Mesoblast Limited
1 day | +0.49% | ||
1 week | -3.29% | ||
Current month | +4.04% | ||
1 month | +37.33% | ||
3 months | +261.40% | ||
6 months | +174.67% | ||
Current year | +232.26% |
Managers | Title | Age | Since |
---|---|---|---|
Silviu Itescu
FOU | Founder | 67 | 04-06-07 |
Andrew Chaponnel
DFI | Director of Finance/CFO | - | 12-05-31 |
Chief Operating Officer | 60 | 20-07-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Rose
CTO | Chief Tech/Sci/R&D Officer | 73 | 13-04-14 |
Joseph Swedish
BRD | Director/Board Member | 72 | 18-06-17 |
William Burns
BRD | Director/Board Member | 76 | 14-03-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 746 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 1.032 | +0.73% | 835 709 |
24-05-16 | 1.025 | -2.38% | 5,571,955 |
24-05-15 | 1.05 | -1.41% | 3,978,990 |
24-05-14 | 1.065 | +1.91% | 3,797,380 |
24-05-13 | 1.045 | -1.88% | 6,155,505 |
Delayed Quote Australian S.E., May 16, 2024 at 08:40 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+232.26% | 801M | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |
- Stock Market
- Equities
- MSB Stock